Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
BridgeBio Oncology Therapeutics Inc.
Market Cap
$283.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.92M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$283.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.29M
Interest Coverage Ratio
-25.79x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
Market Cap
$285.26M
Interest Coverage Ratio
-23.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.74M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$287.49M
Interest Coverage Ratio
-3588.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$291.45M
Interest Coverage Ratio
N/A
TTM Avg
40.84x
3Y Avg
40.84x
5Y Avg
40.84x
Market Cap
$272.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc. (BBOT) | $283.11M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $283.11M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $280.29M | -25.79x | 0.59x | 0.59x | 0.59x |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.26M | -23.92x | N/A | N/A | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.74M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $287.49M | -3588.65x | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.45M | N/A | 40.84x | 40.84x | 40.84x |
| Fate Therapeutics, Inc. (FATE)vs › | $272.01M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.25M | -120.84x | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.01
Current Ratio
4.69
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
